Showing results (1181-1190 of 1,800) with videos related to

Sort By:
Pageof 180
Stem Cell Research|July 23, 2026
Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutationCarla Borisch, Nick Heise, Kristina Sonnenschein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factorBeata Polgar, Gyula Kispal, Margit Lachmann, et al.
Frontiers in Immunology|January 11, 2021
Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler SyndromeShelly Pathak, Dorota Rowczenio, Samuel Lara-Reyna, et al.
Journal of Community Health|March 4, 2020
Knowledge, Attitudes, and Behaviors Related to Hepatitis C Screening and Treatment among Health Care Providers in Washington, DCRupali Kotwal Doshi, Max Ruben, Kate Drezner, et al.
BMC Nephrology|August 22, 2020
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belataceptMira Choi, Friederike Bachmann, Kaiyin Wu, et al.
Critical Care Medicine|October 19, 2007
Surfactant "fortification" by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage modelPhilipp von Bismarck, Karsten Klemm, Carlos-Francisco García Wistädt, et al.
Health Technology Assessment (Winchester, England)|February 16, 2026
Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysisMark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 5, 2024
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer's diseaseBarbara Morgado, Hans-Wolfgang Klafki, Chris Bauer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2025
The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHSMatthew Walton, Nyanar Jasmine Deng, Mark Corbett, et al.
Scientific Reports|October 28, 2020
Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosisMicol Romano, David Piskin, Roberta A Berard, et al.
Pageof 180